Formation of a Stable Oligomer of β-2 Microglobulin Requires only Transient Encounter with Cu(II)

Journal of Molecular Biology

Volumn 367, Issue 1, 2007, Pages 1-7

  Calabrese, Matthew F ^a   Miranker, Andrew D ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

aggregation; amyloid; copper; dialysis; 2 microglobulin

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; COPPER ION; METAL CHELATE;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIALYSIS MEMBRANE; HEMODIALYSIS; METAL BINDING; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN STABILITY;

EID: 33847033822     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.12.034     Document Type: Article

References (47)

1. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8 (1998) 101-106
2. Scherzinger E., Sittler A., Schweiger K., Heiser V., Lurz R., Hasenbank R., et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl Acad. Sci. USA 96 (1999) 4604-4609
3. Davis D.P., Gallo G., Vogen S.M., Dul J.L., Sciarretta K.L., Kumar A., et al. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain. J. Mol. Biol. 313 (2001) 1021-1034
4. Bellotti V., Mangione P., and Merlini G. Review: immunoglobulin light chain amyloidosis-the archetype of structural and pathogenic variability. J. Struct. Biol. 130 (2000) 280-289
5. Zhang Q., Powers E.T., Nieva J., Huff M.E., Dendle M.A., Bieschke J., et al. Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc. Natl Acad. Sci. USA 101 (2004) 4752-4757
6. Hull R.L., Westermark G.T., Westermark P., and Kahn S.E. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J. Clin. Endocrinol. Metab. 89 (2004) 3629-3643
7. Kahn S.E., Andrikopoulos S., and Verchere C.B. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48 (1999) 241-253
8. Morgan C.J., Gelfand M., Atreya C., and Miranker A.D. Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. J. Mol. Biol. 309 (2001) 339-345
9. Gejyo F., Yamada T., Odani S., Nakagawa Y., Arakawa M., Kunitomo T., et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem. Biophys. Res. Commun. 129 (1985) 701-706
10. Floege J., and Ehlerding G. Beta-2-microglobulin-associated amyloidosis. Nephron 72 (1996) 9-26
11. Eakin C.M., and Miranker A.D. From chance to frequent encounters: origins of beta2-microglobulin fibrillogenesis. Biochim. Biophys. Acta 1753 (2005) 92-99
12. Jobling M.F., Huang X., Stewart L.R., Barnham K.J., Curtain C., Volitakis I., et al. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry 40 (2001) 8073-8084
13. Wadsworth J.D., Hill A.F., Joiner S., Jackson G.S., Clarke A.R., and Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nature Cell Bio. 1 (1999) 55-59
14. Uversky V.N., Li J., and Fink A.L. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276 (2001) 44284-44296
15. Rasia R.M., Bertoncini C.W., Marsh D., Hoyer W., Cherny D., Zweckstetter M., et al. Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease. Proc. Natl Acad. Sci. USA 102 (2005) 4294-4299
16. Miura T., Suzuki K., Kohata N., and Takeuchi H. Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 39 (2000) 7024-7031
17. Bush A.I., and Tanzi R.E. The galvanization of beta-amyloid in Alzheimer's disease. Proc. Natl Acad. Sci. USA 99 (2002) 7317-7319
18. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., and Wiley D.C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329 (1987) 506-512
19. Bellotti V., Stoppini M., Mangione P., Sunde M., Robinson C., Asti L., et al. Beta2-microglobulin can be refolded into a native state from ex vivo amyloid fibrils. Eur. J. Biochem. 258 (1998) 61-67
20. Malaguarnera M., Restuccia S., Di Fazio I., Zoccolo A.M., Trovato B.A., and Pistone G. Serum beta2-microglobulin in chronic hepatitis C. Dig. Dis. Sci. 42 (1997) 762-776
21. Keating M.J. Chronic lymphocytic leukemia. Semin. Oncol. 26 (1999) 107-114
22. 1H NMR assignments and secondary structure of human beta 2-microglobulin in solution. Biochemistry 31 (1992) 8906-89015
23. Eakin C.M., Attenello F.J., Morgan C.J., and Miranker A.D. Oligomeric assembly of native-like precursors precedes amyloid formation by beta-2 microglobulin. Biochemistry 43 (2004) 7808-7815
24. Eakin C.M., Berman A.J., and Miranker A.D. A native to amyloidogenic transition regulated by a backbone trigger. Nature Struct. Mol. Biol. 13 (2006) 202-208
25. Jahn T.R., Parker M.J., Homans S.W., and Radford S.E. Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nature Struct. Mol. Biol. 13 (2006) 195-201
26. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
27. Cheng M.F., Liu H.L., Wu A.B., Hsieh R.Y., Guo H.R., and Huang J.J. Clinical characteristics and outcomes of new uremic patients with extreme azotemia in southern Taiwan. Hemodial. Int. 10 (2006) 294-302
28. Kassirer J. Clinical evaluation of kidney function: glomerular function. N. Engl. J. Med. 285 (1971) 385-389
29. Dember L.M., and Jaber B.L. Dialysis-related amyloidosis: late finding or hidden epidemic?. Semin. Dial. 19 (2006) 105-109
30. Hoshino M., Katou H., Hagihara Y., Hasegawa K., Naiki H., and Goto Y. Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nature Struct. Biol. 9 (2002) 332-336
31. McParland V.J., Kalverda A.P., Homans S.W., and Radford S.E. Structural properties of an amyloid precursor of beta(2)-microglobulin. Nature Struct. Biol. 9 (2002) 326-331
32. Jones S., Smith D.P., and Radford S.E. Role of the N and C-terminal strands of beta 2-microglobulin in amyloid formation at neutral pH. J. Mol. Biol. 330 (2003) 935-941
33. Esposito G., Michelutti R., Verdone G., Viglino P., Hernandez H., Robinson C.V., et al. Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci. 9 (2000) 831-845
34. Plakoutsi G., Taddei N., Stefani M., and Chiti F. Aggregation of the Acylphosphatase from Sulfolobus solfataricus: the folded and partially unfolded states can both be precursors for amyloid formation. J. Biol. Chem. 279 (2004) 14111-14119
35. Sambashivan S., Liu Y., Sawaya M.R., Gingery M., and Eisenberg D. Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 437 (2005) 266-269
36. Sanders A., Jeremy Craven C., Higgins L.D., Giannini S., Conroy M.J., Hounslow A.M., et al. Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis. J. Mol. Biol. 336 (2004) 165-178
37. Staniforth R.A., Giannini S., Higgins L.D., Conroy M.J., Hounslow A.M., Jerala R., et al. Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 20 (2001) 4774-4781
38. Villanueva J., Hoshino M., Katou H., Kardos J., Hasegawa K., Naiki H., and Goto Y. Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis. Protein Sci. 13 (2004) 797-809
39. Kameda A., Hoshino M., Higurashi T., Takahashi S., Naiki H., and Goto Y. Nuclear magnetic resonance characterization of the refolding intermediate of beta(2)-microglobulin trapped by non-native prolyl peptide bond. J. Mol. Biol. 348 (2005) 383-397
40. Dobson C.M. An accidental breach of a protein's natural defenses. Nature Struct. Mol. Biol. 13 (2006) 295-297
41. Miranker A.D. Structural biology: fibres hinge on swapped domains. Nature 437 (2005) 197-198
42. Viles J.H., Cohen F.E., Prusiner S.B., Goodin D.B., Wright P.E., and Dyson H.J. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl Acad. Sci. USA 96 (1999) 2042-2047
43. Adams P.L., Stahley M.R., Kosek A.B., Wang J., and Strobel S.A. Crystal structure of a self-splicing group I intron with both exons. Nature 430 (2004) 45-50
44. Laity J.H., Lee B.M., and Wright P.E. Zinc finger proteins: new insights into structural and functional diversity. Cur. Opin. Struct. Biol. 11 (2001) 39-46
45. Cox C., and Lectka T. Synthetic catalysis of amide isomerization. Acc. Chem. Res. 33 (2000) 849-858
46. Stray S.J., Ceres P., and Zlotnick A. Zinc ions trigger conformational change and oligomerization of hepatitis B virus capsid protein. Biochemistry 43 (2004) 9989-9998
47. Eakin C.M., Knight J.D., Morgan C.J., Gelfand M.A., and Miranker A.D. Formation of a copper specific binding site in non-native states of beta-2-microglobulin. Biochemistry 41 (2002) 10646-10656